Macrophage migration inhibitory factor facilitates the therapeutic efficacy of mesenchymal stem cells derived exosomes in acute myocardial infarction through upregulating miR-133a-3p
Exosome transplantation is a promising cell-free therapeutic approach for the treatment of ischemic heart disease. The purpose of this study was to explore whether exosomes derived from Macrophage migration in...
Source: Journal of Nanobiotechnology - Category: Nanotechnology Authors: Wenwu Zhu, Ling Sun, Pengcheng Zhao, Yaowu Liu, Jian Zhang, Yuelin Zhang, Yimei Hong, Yeqian Zhu, Yao Lu, Wei Zhao, Xinguang Chen and Fengxiang Zhang Tags: Research Source Type: research
More News: Cardiology | Heart | Heart Attack | Heart Disease | Heart Transplant | Nanotechnology | Stem Cell Therapy | Stem Cells | Study | Transplants